Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization.
Maier P, Hartmann L, Wenz F, Herskind C. · 2016
Read Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization. by Maier P, Hartmann L, Wenz F, Herskind C. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4730344.txt.
Introduction
Patrick Maier, Linda Hartmann, Frederik Wenz, and Carsten Herskind reviewed how cells respond to ionizing radiation, in the International Journal of Molecular Sciences in 2016. Radiotherapy cures many tumors but is limited twice over: some tumor cells resist it, and normal tissue in the beam gets hurt. Widening that gap needs drugs that sensitize tumors or shield healthy cells, and both need targets. The review maps the pathways a cell runs after irradiation.
DNA double-strand breaks trigger repair programs, cell-cycle halts, and death routes including apoptosis, mitotic catastrophe, and senescence. Key proteins in each route are flagged as drug targets. The authors stress that no sensitizer can be designed without this pathway map, since the same machinery decides survival in tumor and normal cells alike. Their synthesis gives drug hunters a short list of leverage points for making radiotherapy both stronger and gentler.
Catalog record
| CREATOR | Maier P, Hartmann L, Wenz F, Herskind C. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 122 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |